
Luuk de Klein
Articles
-
Jan 23, 2025 |
ionanalytics.com | Luuk de Klein |Tono Gil |John West |Lucy Chapman
The sudden replacement of Competition and Markets Authority (CMA) Chair Markus Bokkerink as part of the UK government’s “growth agenda” has taken the antitrust community by surprise, and raises questions as to how the CMA may change its regulatory approach.
-
Nov 20, 2024 |
ionanalytics.com | Lucy Chapman |John West |Arezki Yaiche |Luuk de Klein
News (Intelligence) Defensive M&A to maintain market access across trading blocsMixed views on scale of possible EU-China rapprochementChinese EV production, tech transfer in EU expected to growGlobal dealmakers have been remarkably optimistic since the US presidential election result, which returns Donald Trump to the White House.
-
Jul 29, 2024 |
ionanalytics.com | Simon Segal |Arezki Yaiche |Luuk de Klein |Keane Hoo
Proposed divestments may not quell regulator’s concerns in fullAntitrust approvals already obtained in France, GermanyOngoing FDI reviews in Europe shouldn’t pose major hurdlesBrookfield’s[NYSE:BAM, TSX:BAM] proposed acquisition of French renewable energy producer Neoen [EPA:NEOEN] is likely to face tough questions from Australia’s competition watchdog – despite the bidder having already submitted a remedy proposal, according to two sources familiar with the situation and an independent lawyer.
-
Apr 8, 2024 |
ionanalytics.com | Dominic Pasteiner |Luuk de Klein |Santosh Shetty |Lloyd Vassell
While the US and Asia-Pacific continue to dominate the global semiconductor industry, Europe’s plan to keep chipping away until it has a bigger piece of the action is gradually starting to yield results. In June, the European Commission (EC) approved plans by 14 member states, including France, Germany and the Netherlands, to provide up to EUR 8.1bn in public funding to support research and development (R&D) in microchips and other semiconductor technologies.
-
Dec 13, 2023 |
ionanalytics.com | Carlos Martinez |Luuk de Klein |Kevin McCaffrey
Two-thirds of deals announced under Biden Administration’s FTC have buyer termination feeAverage amount nearly doubled to 4.76% of deal value from 2.83%Target companies in the healthcare sector are seeking more and higher reverse breakup fees in case their takeover is hampered by US antitrust enforcement, an analysis by this news service shows.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →